MXI1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas

Neoplasia

Volumn 6, Issue 5, 2004, Pages 660-673

  Engstrom, Lars D ^a   Youkilis, Andrew S ^a   Gorelick, Judith L ^a   Zheng, Datong ^a   Ackley, Valerie ^a   Petroff, Christy A ^a   Benson, Linda Q ^a   Coon, Melissa R ^a   Zhu, Xiaoxiang ^a   Hanash, Samir M ^a   Wechsler, Daniel S ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Alternative transcript; Chromosome 10; Gliobiastoma; Mxi1; Myc

Indexed keywords

ISOPROTEIN; MAX PROTEIN; PROTEIN MXI1 0; PROTEIN SIN3; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BRAIN TISSUE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; E BOX ELEMENT; EMBRYO; EXON; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC IDENTIFICATION; GENETIC TRANSCRIPTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 6944239965     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04244     Document Type: Article

References (59)

1. Eisenman RN (2001). Deconstructing myc. Genes Dev 15, 2023-2030.
2. Soucek L and Evan G (2002). Myc - is this the oncogene from hell? Cancer Cell 1, 406-408.
3. Pelengaris S and Khan M (2003). The many faces of c-MYC. Arch Biochem Biophys 416, 129-136.
4. Levens DL (2003). Reconstructing MYC. Genes Dev 17, 1071-1077.
5. Ayer DE, Kretzner L, and Eisenman RN (1993). Mad: a heterodimeric partner for max that antagonizes myc transcriptional activity. Cell 72, 211-222.
6. Zervos AS, Gyuris J, and Brent R (1993). Mxi1, a protein that specifically interacts with max to bind myc-max recognition sites. Cell 72, 223-232.
7. Hurlin PJ, Queva C, Koskinen PJ, Steingrimsson E, Ayer DE, Copeland NG, Jenkins NA, and Eisenman RN (1995). Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-Myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J 14, 5646-5659.
8. Meroni G, Reymond A, Alcalay M, Borsani G, Tanigami A, Tonlorenzi R, Nigro CL, Messali S, Zollo M, Ledbetter DH, et al. (1997). Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J 16, 2892-2906.
9. Hurlin PJ, Queva C, and Eisenman RN (1997). Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev 11, 44-58.
10. Hurlin PJ, Steingrimsson E, Copeland NG, Jenkins NA, and Eisenman RN (1999). Mga, a dual-specificity transcription factor that interacts with Max and contains a T-domain DNA-binding motif. EMBO J 18, 7019-7028.
11. Hurlin PJ, Ayer DE, Grandori C, and Eisenman RN (1994). The max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes. Cold Spring Harbor Symp Quant Biol 59, 109-116.
12. Chin L, Liegeois N, DePinho RA, and Schreiber-Agus N (1996). Functional interactions among members of the Myc superfamily and potential relevance to cutaneous growth and development. J Investig Dermatol Symp Proc 1, 128-135.
13. Luscher B (2001). Function and regulation of the transcription factors of the Myc/Max/Mad network. Gene 277, 1-14.
14. Zhou ZQ and Hurlin PJ (2001). The interplay between Mad and Myc in proliferation and differentiation. Trends Cell Biol 11, S10-S14.
15. Shapiro DN, Valentine V, Eagle L, Yin X, Morris SW, and Prochownik EV (1994). Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Genomics 23, 282-285.
16. Wechsler DS, Hawkins AL, Li X, Jabs EW, Griffin CA, and Dang CV (1994). Localization of the human Mxi1 transcription factor gene (MXI1) to chromosome 10q24-q25. Genomics 21, 669-672.
17. Wechsler DS, Shelly CA, and Dang CV (1996). Genomic organization of human MXI1, a putative tumor suppressor gene. Genomics 32, 466-470.
18. Ayer DE, Lawrence QA, and Eisenman RN (1995). Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast represser Sin3. Cell 80, 767-776.
19. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI, and DePinho RA (1995). An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional represser Sin3. Cell 80, 777-786.
20. Harper SE, Qiu Y, and Sharp PA (1996). Sin3 corepressor function in Myc-induced transcription and transformation. Proc Natl Acad Sci USA 93, 8536-8540.
21. Rao G, Alland L, Guida P, Schreiber-Agus N, Chen K, Chin L, Rochelle JM, Seidin MF, Skoultchi AI, and DePinho RA (1996). Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1. Oncogene 12, 1165-1172.
22. Alland L, Muhle R, Hou H Jr, Poles J, Chin L, Schreiber-Agus N, and DePinho RA (1997). Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387, 49-55.
23. Wechsler DS, Shelly CA, Petroff CA, and Dang CV (1997). Mxi1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res 57, 4905-4912.
24. Taj MM, Tawil RJ, Engstrom LD, Zeng Z, Hwang C, Sanda MG, and Wechsler DS (2001). Mxi1, a Myc antagonist, suppresses proliferation of DU145 human prostate cells. Prostate 47, 194-204.
25. Manni I, Tunici P, Cirenei N, Albarosa R, Colombo BM, Roz L, Sacchi A, Piaggio G, and Finocchiaro G (2002). Mxi1 inhibits the proliferation of U87 glioma cells through down-regulation of cyclin B1 gene expression. Br J Cancer 86, 477-484.
26. Schreiber-Agus N, Meng Y, Hoang T, Hou H Jr, Chen K, Greenberg R, Cordon-Cardo C, Lee HW, and DePinho RA (1998). Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature 393, 483-487.
27. Kawamata N, Park D, Wilczynski S, Yokota J, and Koeffler HP (1996). Point mutations of the Mxi1 gene are rare in prostate cancers. Prostate 29, 191-193.
28. Li XJ, Wang DY, Zhu Y, Quo RJ, Wang XD, Lubomir K, Mukai K, Sasaki H, Yoshida H, Oka T, et al. (1999). Mxi1 mutations in human neurofibrosarcomas. Jpn J Cancer Res 90, 740-746.
29. Raja S, Finkelstein SD, Baksh FK, Gooding WE, Swalsky PA, Godfrey TE, Buenaventura PO, and Luketich JD (2001). Correlation between dysplasia and mutations of six tumor suppressor genes in Barrett's esophagus. Ann Thorac Surg 72, 1130-1135.
30. O'Hagan RC, Schreiber-Agus N, Chen K, David G, Engelman JA, Schwab R, Alland L, Thomson C, Ronning DR, Sacchettini JC, et al. (2000). Gene-target recognition among members of the Myc superfamily and implications for oncogenesis. Nat Genet 24, 113-119.
31. Shimizu E, Shirasawa H, Kodama K, Koseki K, Sato T, and Simizu B (1995). Cloning and sequencing of the murine Mxi1 cDNA. Gene 152, 283-284.
32. Shimizu E, Shirasawa H, Kodama K, Sato T, and Simizu B (1996). Expression, regulation and polymorphism of the mxi1 genes. Gene 176, 45-48.
33. Shim H, Lewis BC, Dolde C, Li Q, Wu CS, Chun YS, and Dang CV (1997). Myc target genes in neoplastic transformation. Curr Top Microbiol Immunol 224, 181-190.
34. Hatada I, Hayashizaki Y, Hirotsune S, Komatsubara H, and Mukai T (1991). A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci USA 88, 9523-9527.
35. Hayashizaki Y, Hirotsune S, Okazaki Y, Hatada I, Shibata H, Kawai J, Hirose K, Watanabe S, Fushiki S, Wada S, et al. (1993). Restriction landmark genomic scanning method and its various applications. Electrophoresis 14, 251-258.
36. Rouillard JM, Erson AE, Kuick R, Asakawa J, Wimmer K, Muleris M, Petty EM, and Hanash S (2001). Virtual genome scan: a tool for restriction landmark-based scanning of the human genome. Genome Res 11, 1453-1459.
37. Zhu X, Wimmer K, Kuick R, Lamb BJ, Motyka S, Jasty R, Castle VP, and Hanash SM (2002). N-myc modulates expression of p73 in neuroblastoma. Neoplasia 4, 432-439.
38. Wimmer K, Zhu XX, Rouillard JM, Ambros PF, Lamb BJ, Kuick R, Eckart M, Weinhausl A, Fonatsch C, and Hanash SM (2002). Combined restriction landmark genomic scanning and virtual genome scans identify a novel human homeobox gene, ALX3, that is hypermethylated in neuroblastoma. Genes Chromosomes Cancer 33, 285-294.
39. Benson LQ, Coon MR, Krueger LM, Han GC, Sarnaik AA, and Wechsler DS (1999). Expression of MXI1, a Myc antagonist, is regulated by Sp1 and AP2. J Biol Chem 274, 28794-28802.
40. Wechsler DS and Dang CV (1992). Opposite orientations of DNA bending by c-Myc and Max. Proc Natl Acad Sci USA 89, 7635-7639.
41. Yin X, Landay MF, Han W, Levitan ES, Watkins SC, Levenson RM, Farkas DL, and Prochownik EV (2001). Dynamic in vivo interactions among Myc network members. Oncogene 20, 4650-4664.
42. Zhang T, Haws P, and Wu Q (2004). Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. Genome Res 14, 79-89.
43. Cote F, Boisvert FM, Grondin B, Bazinet M, Goodyer CG, Bazett-Jones DP, and Aubry M (2001). Alternative promoter usage and splicing of ZNF74 multifinger gene produce protein isoforms with a different repressor activity and nuclear partitioning. DNA Cell Biol 20, 159-173.
44. Brown CY, Mize GJ, Pineda M, George DL, and Morris DR (1999). Role of two upstream open reading frames in the translational control of oncogene mdm2. Oncogene 18, 5631-5637.
45. Ge K, DuHadaway J, Du W, Herlyn M, Rodeck U, and Prendergast GC (1999). Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc Natl Acad Sci USA 96, 9689-9694.
46. Tajiri T, Liu X, Thompson PM, Tanaka S, Suita S, Zhao H, Maris JM, Prendergast GC, and Hogarty MD (2003). Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features. Clin Cancer Res 9, 3345-3355.
47. Ayoubi TA and Van De Ven WJ (1996). Regulation of gene expression by alternative promoters. FASEB J 10, 453-460.
48. Mercatante D and Kole R (2000). Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol Ther 85, 237-243.
49. Foley Kp and Eisenman RN (1999). Two MAD tails: what the recent knockouts of Mad1 and Mxi1 tell us about the MYC/MAX/MAD network. Biochim Biophys Acta 1423, M37-47.
50. Queva C, McArthur GA, Iritani BM, and Eisenman RN (2001). Targeted deletion of the S-phase-specific Myc antagonist Mad3 sensitizes neuronal and lymphoid cells to radiation-induced apoptosis. Mol Cell Biol 21, 703-712.
51. Nikolaev AY, Li M, Puskas N, Qin J, and Gu W (2003). Parc: a cytoplasmic anchor for p53. Cell 112, 29-40.
52. Nikolaev AY and Gu W (2003). PARC: a potential target for cancer therapy. Cell Cycle 2, 169-171.
53. Kawamata N, Sakajiri S, Sugimoto K-J, and Koeffler HP (2003). Alternative isoforms of the Mxi1 gene are expressed in hematological cell lines and normal bone marrow. Blood 102, 203.
54. Fults D, Pedone CA, Thompson GE, Uchiyama CM, Gumpper KL, Iliev D, Vinson VL, Tavtigian SV, and Perry WL III (1998). Microsatellite deletion mapping on chromosome 10q and mutation analysis of MMAC1, FAS, and MXI1 in human glioblastoma multiforme. Int J Oncol 12, 905-910.
55. Larsson LG, Pettersson M, Oberg F, Nilsson K, and Luscher B (1994). Expression of mad, mxh, max and c-myc during induced differentiation of hematopoietic cells: opposite regulation of mad and c-myc. Oncogene 9, 1247-1252.
56. Delgado MD, Lerga A, Canelles M, Gomez-Casares MT, and Leon J (1995). Differential regulation of Max and role of c-Myc during erythroid and myelomonocytic differentiation of K562 cells. Oncogene 10, 1659-1665.
57. Dooley S, Wundrack I, Blin N, and Welter C (1995). Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription. Biochem Biophys Res Commun 213, 789-795.
58. Meinhardt G and Hass R (1995). Differential expression of c-myc, max and mxi1 in human myeloid leukemia cells during retrodifferentiation and cell death. Leuk Res 19, 699-705.
59. Wang Y, Toury R, Hauchecorne M, and Balmain N (1997). Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats. Cell Mol Biol 43, 175-188.